Design of mutated forms of human serum albumin with altered metal binding characteristics for pharmacological or cell culture uses.

Stephen Berezenko; Peter J Sadler; Alan James Stewart; Claudia A Blindauer; Kerry E Bunyan

Design of mutated forms of human serum albumin with altered metal binding characteristics for pharmacological or cell culture uses.

Stephen Berezenko (Inventor), Peter J Sadler (Inventor), Alan James Stewart (Inventor), Claudia A Blindauer (Inventor), Kerry E Bunyan (Inventor)

Research output: Patent

Abstract

The present invention relates to mutated forms of serum albumin, which display altered metal binding and/or other characteristics with respect to a native albumin from which the mutant has been derived, as well as uses of such mutant albumins in the medical field or in growth of cells in culture.

Original language	English
Patent number	WO/2004/011499
IPC	C07K 14/765 (2006.01)
Publication status	Published - 5 Feb 2004

Cite this

@misc{4feab3450d64459a8eecd7814b2a4626,

title = "Design of mutated forms of human serum albumin with altered metal binding characteristics for pharmacological or cell culture uses.",

abstract = "The present invention relates to mutated forms of serum albumin, which display altered metal binding and/or other characteristics with respect to a native albumin from which the mutant has been derived, as well as uses of such mutant albumins in the medical field or in growth of cells in culture.",

author = "Stephen Berezenko and Sadler, {Peter J} and Stewart, {Alan James} and Blindauer, {Claudia A} and Bunyan, {Kerry E}",

year = "2004",

month = feb,

day = "5",

language = "English",

type = "Patent",

note = "WO/2004/011499; C07K 14/765 (2006.01)",

}

TY - PAT

T1 - Design of mutated forms of human serum albumin with altered metal binding characteristics for pharmacological or cell culture uses.

AU - Berezenko, Stephen

AU - Sadler, Peter J

AU - Stewart, Alan James

AU - Blindauer, Claudia A

AU - Bunyan, Kerry E

PY - 2004/2/5

Y1 - 2004/2/5

N2 - The present invention relates to mutated forms of serum albumin, which display altered metal binding and/or other characteristics with respect to a native albumin from which the mutant has been derived, as well as uses of such mutant albumins in the medical field or in growth of cells in culture.

AB - The present invention relates to mutated forms of serum albumin, which display altered metal binding and/or other characteristics with respect to a native albumin from which the mutant has been derived, as well as uses of such mutant albumins in the medical field or in growth of cells in culture.

M3 - Patent

M1 - WO/2004/011499

ER -

Design of mutated forms of human serum albumin with altered metal binding characteristics for pharmacological or cell culture uses.

Abstract

Fingerprint

Cite this